Form 4: Expensify CEO David Barrett Executes Stock Transactions Under 10b5-1 Plan

Expensify's CEO, David Barrett, engaged in multiple stock transactions, including the sale of shares to cover taxes related to vested restricted stock units, under a pre-arranged 10b5-1 trading plan.

Summary

• David Barrett, CEO of Expensify, executed several transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• These transactions included the acquisition of 14,463 shares through the settlement of vested RSUs on December 15, 2024.
• He also sold 13,272 shares on December 16, 2024, at an average price of $3.84 per share to cover taxes related to vested RSUs for certain employees.
• Additionally, 5,985 shares were granted as matched shares under the SPMP on December 16, 2024.
• Further sales of 68,380 shares on December 16, 3,320 shares on December 17, 70,000 shares on December 17, and 6,152 shares on December 18 were executed under a 10b5-1 trading plan.
• The sales were conducted at weighted average prices ranging from $3.81 to $3.84 per share.
• Barrett also settled 14,463 RSUs for Class A common stock and 14,463 RSUs for LT50 common stock on December 15, 2024.
• The LT50 common stock is convertible into Class A common stock on a one-to-one basis under certain conditions.

Sentiment

Score: 6

Explanation: The document reflects routine transactions by the CEO under a pre-arranged plan. While the sales could be perceived negatively, the use of a 10b5-1 plan mitigates concerns. The sentiment is neutral to slightly positive due to the transparency.

Positives

• The acquisition of shares through RSU settlement indicates continued alignment of the CEO's interests with the company's performance.
• The use of a 10b5-1 trading plan provides transparency and avoids accusations of insider trading.

Negatives

• The sale of a significant number of shares by the CEO could be perceived negatively by some investors, although it is part of a pre-arranged plan.
• The sales were primarily to cover tax obligations, which may not be viewed as a strategic move.

Risks

• Continued sales by the CEO, even under a 10b5-1 plan, could put downward pressure on the stock price.
• The complexity of the LT50 common stock and its conversion terms could create confusion among investors.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This type of filing is common for executives of publicly traded companies and is a routine disclosure of stock transactions. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, such as those at Salesforce (CRM) and Workday (WDAY), to manage their stock sales in a compliant manner.
• The vesting schedule of the RSUs, with a portion vesting initially and then quarterly, is a typical structure seen in many tech companies, similar to those at Atlassian (TEAM) and Zoom (ZM).
• The weighted average price sales are also common, and the ranges provided are similar to what is seen in other Form 4 filings.
• The LT50 common stock structure is less common and may be specific to Expensify's capital structure, which is not directly comparable to most other companies.

Stakeholder Impact

• Shareholders may react to the stock sales, although the 10b5-1 plan provides some reassurance.
• Employees who received RSUs may be impacted by the tax-related sales.

Key Dates

Keywords

Expensify, David Barrett, stock transactions, Form 4, 10b5-1 trading plan, restricted stock units, RSU, Class A Common Stock, LT50 Common Stock, insider trading